Evidence map›Paper›PMID 20371544›Full record

ArticleHuman molecular genetics2010

Mutations in MUSK causing congenital myasthenic syndrome impair MuSK-Dok-7 interaction.

Ricardo A Maselli, Juan Arredondo, Orla Cagney, Jarae J Ng, Jennifer A Anderson, Colette Williams, Bae J Gerke, Betty Soliven, Robert L Wollmann

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Human molecular genetics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 2 pooled it
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 2 syntheses or guidelines pooled it, 96 citations in OpenAlex.

  1. Congenital myasthenic syndromes.Orphanet journal of rare diseases · 2019
    Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Motor function recovery: deciphering a regenerative niche at the neuromuscular synapse.Biological reviews of the Cambridge Philosophical Society · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ricardo A MaselliDepartment of Neurology, School of Veterinary Medicine, University of California Davis, Davis, CA 95618, USA. ramaselli@ucdavis.edu
Juan Arredondo
Orla Cagney
Jarae J Ng
Jennifer A Anderson
Colette Williams
Bae J Gerke
Betty Soliven
Robert L Wollmann
University of California, Davis · USUniversity of Chicago · US

Funding

Congenital Myasthenic Syndromes: Pathogenic MechanismsR01NS049117 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI MASELLI, RICARDO ANIBAL · 2010 to 2014
$1.6M
NINDS NIH HHS R01NS049117-01
6 · The paper itself

Abstract

We describe a severe congenital myasthenic syndrome (CMS) caused by two missense mutations in the gene encoding the muscle specific receptor tyrosine kinase (MUSK). The identified MUSK mutations M605I and A727V are both located in the kinase domain of MuSK. Intracellular microelectrode recordings and microscopy studies of the neuromuscular junction conducted in an anconeus muscle biopsy revealed decreased miniature endplate potential amplitudes, reduced endplate size and simplification of secondary synaptic folds, which were consistent with postsynaptic deficit. The study also showed a striking reduction of the endplate potential quantal content, consistent with additional presynaptic failure. Expression studies in MuSK deficient myotubes revealed that A727V, which is located within the catalytic loop of the enzyme, caused severe impairment of agrin-dependent MuSK phosphorylation, aggregation of acetylcholine receptors (AChRs) and interaction of MuSK with Dok-7, an essential intracellular binding protein of MuSK. In contrast, M605I, resulted in only moderate impairment of agrin-dependent MuSK phosphorylation, aggregation of AChRs and interaction of MuSK with Dok-7. There was no impairment of interaction of mutants with either the low-density lipoprotein receptor-related protein, Lrp4 (a co-receptor of agrin) or with the mammalian homolog of the Drosophila tumorous imaginal discs (Tid1). Our findings demonstrate that missense mutations in MUSK can result in a severe form of CMS and indicate that the inability of MuSK mutants to interact with Dok-7, but not with Lrp4 or Tid1, is a major determinant of the pathogenesis of the CMS caused by MUSK mutations.

Indexed as

AgrinAnimalsCell LineFemaleHSP40 Heat-Shock ProteinsHumansMiceMuscle ProteinsMuscle, SkeletalMutation, MissenseMyasthenic Syndromes, CongenitalNeuromuscular JunctionProtein Structure, SecondaryReceptor Protein-Tyrosine KinasesReceptors, CholinergicReceptors, Growth FactorAgrinagrin receptorDNAJA3 protein, humanDOK7 protein, humanHSP40 Heat-Shock ProteinsMuscle ProteinsMUSK protein, humanReceptor Protein-Tyrosine KinasesReceptors, CholinergicReceptors, Growth Factor

Identifiers

PMID20371544
PMCPMC2876883
OpenAlexW2113602915

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.